Jerry J. Buccafusco - Publications

Medical College of Georgia, Augusta, GA, United States 
Neuroscience Biology, Molecular Biology, Cell Biology

159 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Webster SJ, Mruthinti S, Hill WD, Buccafusco JJ, Terry AV. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Medicine. 14: 119-30. PMID 22415896 DOI: 10.1007/S12017-012-8176-Z  0.558
2012 Terry AV, Buccafusco JJ, Schade RF, Vandenhuerk L, Callahan PM, Beck WD, Hutchings EJ, Chapman JM, Li P, Bartlett MG. The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. Biochemical Pharmacology. 83: 941-51. PMID 22244928 DOI: 10.1016/J.Bcp.2011.12.043  0.656
2011 Hall BJ, Pearson LS, Terry AV, Buccafusco JJ. The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 61: 798-806. PMID 21651919 DOI: 10.1016/J.Neuropharm.2011.05.026  0.607
2011 Webster SJ, Wilson CA, Lee CH, Mohler EG, Terry AV, Buccafusco JJ. The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8. PMID 21486290 DOI: 10.1111/J.1476-5381.2011.01432.X  0.63
2011 Terry AV, Buccafusco JJ, Gearhart DA, Beck WD, Middlemore-Risher ML, Truan JN, Schwarz GM, Xu M, Bartlett MG, Kutiyanawala A, Pillai A. Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience. 176: 237-53. PMID 21185910 DOI: 10.1016/J.Neuroscience.2010.12.031  0.631
2011 Terry AV, Buccafusco JJ, Herman EJ, Callahan PM, Beck WD, Warner S, Vandenhuerk L, Bouchard K, Schwarz GM, Gao J, Chapman JM. The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models. The Journal of Pharmacology and Experimental Therapeutics. 336: 751-66. PMID 21106907 DOI: 10.1124/Jpet.110.175422  0.672
2011 Rueter LE, Rêlo AL, van Gaalen MM, Ballard ME, Terry AV, Buccafusco J, Zhang M. The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents/monkeys to humans: Preclinical evidences Biochemical Pharmacology. 82: 1043. DOI: 10.1016/J.Bcp.2011.07.052  0.569
2011 Kohlhaas KL, Robb H, Roderwald V, Markosyan S, Salte K, Bitner RS, Mohler E, Terry AV, Buccafusco J, Rueter LE, Lee L, Gopalakrishnan M. α7 NNR allosteric modulation in behavioral models of cognition Biochemical Pharmacology. 82: 1042. DOI: 10.1016/J.Bcp.2011.07.050  0.537
2010 Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC, Thomasson-Perret N, Hill M, Mocaer E, Schneider JS. The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1035-51. PMID 20663270 DOI: 10.1017/S1461145710000775  0.447
2010 Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, Anderson DJ, Buccafusco J, Gopalakrishnan M. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics. 334: 875-86. PMID 20504913 DOI: 10.1124/Jpet.110.167213  0.47
2010 Mitchell MB, Buccafusco JJ, Schade RF, Webster SJ, Mruthinti S, Harrell DU, Gulati NK, Miller LS. RAGE and Abeta immunoglobulins: relation to Alzheimer's disease-related cognitive function. Journal of the International Neuropsychological Society : Jins. 16: 672-8. PMID 20441687 DOI: 10.1017/S1355617710000469  0.331
2010 Shineman DW, Salthouse TA, Launer LJ, Hof PR, Bartzokis G, Kleiman R, Luine V, Buccafusco JJ, Small GW, Aisen PS, Lowe DA, Fillit HM. Therapeutics for cognitive aging. Annals of the New York Academy of Sciences. 1191: E1-15. PMID 20392284 DOI: 10.1111/J.1749-6632.2010.05532.X  0.33
2010 Middlemore-Risher ML, Buccafusco JJ, Terry AV. Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats. Neurotoxicology and Teratology. 32: 415-24. PMID 20350597 DOI: 10.1016/J.Ntt.2010.03.008  0.589
2010 Hall BJ, Pearson LS, Buccafusco JJ. Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats. Neuroscience Letters. 474: 84-7. PMID 20226229 DOI: 10.1016/J.Neulet.2010.03.011  0.317
2010 Buccafusco JJ, Terry AV, Vazdarjanova A, Snutch TP, Arneric SP. Treatments for neuropathic pain differentially affect delayed matching accuracy by macaques: effects of amitriptyline and gabapentin. Pain. 148: 446-53. PMID 20092945 DOI: 10.1016/J.Pain.2009.12.003  0.63
2010 Hall BJ, Pearson LS, Buccafusco JJ. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal. Neuropharmacology. 58: 429-35. PMID 19772864 DOI: 10.1016/J.Neuropharm.2009.09.009  0.443
2009 Buccafusco JJ. Emerging cognitive enhancing drugs. Expert Opinion On Emerging Drugs. 14: 577-89. PMID 19772371 DOI: 10.1517/14728210903257796  0.35
2009 Buccafusco JJ, Terry AV. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochemical Pharmacology. 78: 852-62. PMID 19577545 DOI: 10.1016/J.Bcp.2009.06.102  0.67
2009 Buccafusco JJ. Multifunctional receptor-directed drugs for disorders of the central nervous system. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 4-13. PMID 19110195 DOI: 10.1016/J.Nurt.2008.10.031  0.318
2009 Buccafusco JJ, Beach JW, Terry AV. Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. The Journal of Pharmacology and Experimental Therapeutics. 328: 364-70. PMID 19023041 DOI: 10.1124/Jpet.108.145292  0.688
2009 Buccafusco JJ, Webster SJ, Terry AV, Kille N, Blessing D. Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task. Psychopharmacology. 202: 477-85. PMID 18784917 DOI: 10.1007/S00213-008-1318-1  0.636
2008 Buccafusco JJ. Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders. Journal of Alzheimer's Disease : Jad. 15: 709-20. PMID 19096166 DOI: 10.3233/Jad-2008-15414  0.407
2008 Terry AV, Buccafusco JJ, Wilson C. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets. Behavioural Brain Research. 195: 30-8. PMID 18241938 DOI: 10.1016/J.Bbr.2007.12.006  0.582
2008 Buccafusco JJ, Terry AV, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology. 199: 481-94. PMID 17657478 DOI: 10.1007/S00213-007-0887-8  0.607
2008 Buccafusco JJ, Terry AV, Webster SJ. O4-04-01: Prolonged cognitive enhancement exhibited by monkeys after single doses of clonidine Alzheimer's & Dementia. 4: T190-T191. DOI: 10.1016/J.Jalz.2008.05.527  0.564
2008 Gopalakrishnan M, Anderson D, Bunnelle W, Briggs C, Buccafusco J, Curzon P, Decker M, Hu M, Li J, Malysz J, Markosyan S, Nikkel A, Radek R, Robb H, Bitner R. P2-477: Evidence for broad spectrum symptomatic efficacy across cognitive domains and potential for disease modification in Alzheimer's disease revealed by the novel alpha-7 neuronal nicotinic receptor agonist A-582941 Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1555  0.404
2007 Buccafusco JJ, Bain JN. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline. Neuroscience. 149: 487-98. PMID 17916413 DOI: 10.1016/J.Neuroscience.2007.07.027  0.352
2007 Bitner RS, Bunnelle WH, Anderson DJ, Briggs CA, Buccafusco J, Curzon P, Decker MW, Frost JM, Gronlien JH, Gubbins E, Li J, Malysz J, Markosyan S, Marsh K, Meyer MD, et al. Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10578-87. PMID 17898229 DOI: 10.1523/Jneurosci.2444-07.2007  0.445
2007 Buccafusco JJ, Terry AV, Decker MW, Gopalakrishnan M. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochemical Pharmacology. 74: 1202-11. PMID 17706609 DOI: 10.1016/J.Bcp.2007.07.010  0.676
2007 Sood A, Warren Beach J, Webster SJ, Terry AV, Buccafusco JJ. The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys. Neuropharmacology. 53: 588-600. PMID 17698153 DOI: 10.1016/J.Neuropharm.2007.06.028  0.729
2007 Terry AV, Gearhart DA, Beck WD, Truan JN, Middlemore ML, Williamson LN, Bartlett MG, Prendergast MA, Sickles DW, Buccafusco JJ. Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. The Journal of Pharmacology and Experimental Therapeutics. 322: 1117-28. PMID 17548533 DOI: 10.1124/Jpet.107.125625  0.613
2007 Buccafusco JJ, Powers JC, Hernandez MA, Prendergast MA, Terry AV, Jonnala RR. MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition. Neurochemical Research. 32: 1224-37. PMID 17404838 DOI: 10.1007/S11064-007-9294-0  0.803
2007 Prendergast MA, Self RL, Smith KJ, Ghayoumi L, Mullins MM, Butler TR, Buccafusco JJ, Gearhart DA, Terry AV. Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity. Neuroscience. 146: 330-9. PMID 17321052 DOI: 10.1016/J.Neuroscience.2007.01.023  0.569
2007 Buccafusco JJ, Shuster LC, Terry AV. Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine. Neuroscience Letters. 413: 68-71. PMID 17157984 DOI: 10.1016/J.Neulet.2006.11.028  0.667
2007 Gearhart DA, Sickles DW, Buccafusco JJ, Prendergast MA, Terry AV. Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility. Toxicology and Applied Pharmacology. 218: 20-9. PMID 17123561 DOI: 10.1016/J.Taap.2006.10.008  0.546
2007 Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190: 269-319. PMID 16896961 DOI: 10.1007/S00213-006-0441-0  0.424
2007 Buccafusco JJ, Powers JC, Hernandez MA, Prendergast MA, Terry AV, Jonnala RR. Erratum: MHP-133, a drug with multiple CNS targets: Potential for neuroprotection and enhanced cognition (Neurochemical Research 32, 7, (1224-1237) DOI: 10.1007/s11064-007-9294-0) Neurochemical Research. 32. DOI: 10.1007/S11064-007-9489-4  0.762
2006 Khan MM, Hadman M, De Sevilla LM, Mahesh VB, Buccafusco J, Hill WD, Brann DW. Cloning, distribution, and colocalization of MNAR/PELP1 with glucocorticoid receptors in primate and nonprimate brain. Neuroendocrinology. 84: 317-29. PMID 17142998 DOI: 10.1159/000097746  0.337
2006 Mruthinti S, Sood A, Humphrey CL, Swamy-Mruthinti S, Buccafusco JJ. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products. Neuroscience. 142: 463-73. PMID 16890367 DOI: 10.1016/J.Neuroscience.2006.06.010  0.591
2006 Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology. 148: 565-78. PMID 16751797 DOI: 10.1038/Sj.Bjp.0706780  0.383
2005 Terry AV, Hernandez CM, Hohnadel EJ, Bouchard KP, Buccafusco JJ. Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition. Cns Drug Reviews. 11: 229-52. PMID 16389292 DOI: 10.1111/J.1527-3458.2005.Tb00045.X  0.686
2005 Li XD, Arias E, Jonnala RR, Mruthinti S, Buccafusco JJ. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo. Journal of Molecular Neuroscience : Mn. 27: 325-36. PMID 16280603 DOI: 10.1385/Jmn:27:3:325  0.812
2005 Graham JH, Papke RL, Buccafusco JJ. Functional central nicotinic acetylcholine receptor antagonism by systemic administration of Tinuvin 770 (BTMPS). Current Alzheimer Research. 2: 141-7. PMID 15974911 DOI: 10.2174/1567205053585747  0.501
2005 Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM. Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends in Pharmacological Sciences. 26: 352-60. PMID 15946748 DOI: 10.1016/J.Tips.2005.05.007  0.447
2005 Youdim MB, Buccafusco JJ. CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 519-37. PMID 15666041 DOI: 10.1007/s00702-004-0214-z  0.337
2005 Youdim MB, Buccafusco JJ. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends in Pharmacological Sciences. 26: 27-35. PMID 15629202 DOI: 10.1016/J.Tips.2004.11.007  0.364
2005 Terry AV, Buccafusco JJ, Bartoszyk GD. Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys. Psychopharmacology. 179: 725-32. PMID 15619109 DOI: 10.1007/S00213-004-2114-1  0.597
2005 Buccafusco JJ, Davis JA, Shuster LC, Buccafusco CJ, Gattu M. The importance of brainstem cholinergic neurons in the pressor response to cocaine. The Journal of Pharmacology and Experimental Therapeutics. 312: 179-91. PMID 15328378 DOI: 10.1124/Jpet.104.073619  0.383
2004 Buccafusco JJ, Beach JW, Terry AV, Doad GS, Sood A, Arias E, Misawa H, Masai M, Fujii T, Kawashima K. Novel analogs of choline as potential neuroprotective agents. Journal of Alzheimer's Disease : Jad. 6: S85-92. PMID 15665419 DOI: 10.3233/Jad-2004-6S612  0.756
2004 Buccafusco JJ. Neuronal nicotinic receptor subtypes: defining therapeutic targets. Molecular Interventions. 4: 285-95. PMID 15471911 DOI: 10.1124/Mi.4.5.8  0.428
2004 Buccafusco JJ, Terry AV. Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys. Journal of Molecular Neuroscience : Mn. 24: 85-91. PMID 15314255 DOI: 10.1385/Jmn:24:1:085  0.631
2004 Li XD, Buccafusco JJ. Role of alpha7 nicotinic acetylcholine receptors in the pressor response to intracerebroventricular injection of choline: blockade by amyloid peptide Abeta1-42. The Journal of Pharmacology and Experimental Therapeutics. 309: 1206-12. PMID 14976229 DOI: 10.1124/Jpet.103.063321  0.56
2004 Buccafusco JJ, Weiser T, Winter K, Klinder K, Terry AV. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology. 46: 10-22. PMID 14654093 DOI: 10.1016/J.Neuropharm.2003.07.002  0.655
2004 Pangalos MN, Smith DL, Rosenzweig-Lipson S, Sukoff S, Dawson L, Marquis K, Jones D, Piesla M, Andree T, Harder J, Womack M, Buccafusco J, Terry AV, Hoebel B, Rada P, et al. P1-319 SRA-333: a novel 5-HT1A receptor antagonist with procognitive properties in nonhuman primates Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80632-8  0.334
2003 Li XD, Buccafusco JJ. Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells. The Journal of Pharmacology and Experimental Therapeutics. 307: 670-5. PMID 12970390 DOI: 10.1124/Jpet.103.053785  0.544
2003 Buccafusco JJ, Terry AV, Goren T, Blaugrun E. Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task. Neuroscience. 119: 669-78. PMID 12809688 DOI: 10.1016/S0306-4522(02)00937-5  0.609
2003 Terry AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. The Journal of Pharmacology and Experimental Therapeutics. 306: 821-7. PMID 12805474 DOI: 10.1124/Jpet.102.041616  0.613
2003 Bain JN, Prendergast MA, Terry AV, Arneric SP, Smith MA, Buccafusco JJ. Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology. 169: 150-60. PMID 12768267 DOI: 10.1007/S00213-003-1483-1  0.584
2003 Buccafusco JJ, Terry AV. The potential role of cotinine in the cognitive and neuroprotective actions of nicotine. Life Sciences. 72: 2931-42. PMID 12706481 DOI: 10.1016/S0024-3205(03)00226-1  0.675
2003 Terry AV, Stone JD, Buccafusco JJ, Sickles DW, Sood A, Prendergast MA. Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning. The Journal of Pharmacology and Experimental Therapeutics. 305: 375-84. PMID 12649392 DOI: 10.1124/Jpet.102.041897  0.684
2003 Buccafusco JJ, Jackson WJ, Stone JD, Terry AV. Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys. Neuropharmacology. 44: 381-9. PMID 12604096 DOI: 10.1016/S0028-3908(02)00378-7  0.627
2003 Jonnala RR, Graham JH, Terry AV, Beach JW, Young JA, Buccafusco JJ. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. Synapse (New York, N.Y.). 47: 262-9. PMID 12539199 DOI: 10.1002/Syn.10176  0.807
2002 Buccafusco JJ, Terry AV, Murdoch PB. A computer-assisted cognitive test battery for aged monkeys. Journal of Molecular Neuroscience : Mn. 19: 179-85. PMID 12212778 DOI: 10.1007/S12031-002-0030-6  0.595
2002 Terry AV, Buccafusco JJ, Borsini F, Leusch A. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine. Psychopharmacology. 162: 292-300. PMID 12122487 DOI: 10.1007/S00213-002-1105-3  0.633
2002 Terry AV, Risbrough VB, Buccafusco JJ, Menzaghi F. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. The Journal of Pharmacology and Experimental Therapeutics. 301: 284-92. PMID 11907185 DOI: 10.1124/Jpet.301.1.284  0.638
2002 Jonnala RR, Terry AV, Buccafusco JJ. Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sciences. 70: 1543-54. PMID 11895105 DOI: 10.1016/S0024-3205(01)01529-6  0.817
2001 Jonnala RR, Buccafusco JJ. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. Journal of Neuroscience Research. 66: 565-72. PMID 11746376 DOI: 10.1002/Jnr.10022  0.816
2001 Terry AV, Hernandez CM, Buccafusco JJ. Dahl salt-sensitive and salt-resistant rats: Examination of learning and memory performance, blood pressure, and the expression of central nicotinic acetylcholine receptors Neuroscience. 103: 351-363. PMID 11246150 DOI: 10.1016/S0306-4522(00)00569-8  0.657
2001 Jonnala RR, Buccafusco JJ. Inhibition of nerve growth factor signaling by peroxynitrite. Journal of Neuroscience Research. 63: 27-34. PMID 11169611 DOI: 10.1002/1097-4547(20010101)63:1<27::Aid-Jnr4>3.0.Co;2-#  0.782
2000 Terry AV, Hernandez CM, Buccafusco JJ, Gattu M. Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats Neuroscience. 101: 357-368. PMID 11074159 DOI: 10.1016/S0306-4522(00)00377-8  0.662
2000 Stone JD, Terry AV, Pauly JR, Prendergast MA, Buccafusco JJ. Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Research. 882: 9-18. PMID 11056179 DOI: 10.1016/S0006-8993(00)02689-5  0.683
2000 Evans-Martin FF, Terry AV, Jackson WJ, Buccafusco JJ. Evaluation of two rodent delayed-response memory tasks: a method with retractable levers versus a method with closing doors. Physiology & Behavior. 70: 233-41. PMID 11006421 DOI: 10.1016/S0031-9384(00)00233-X  0.626
2000 Zhang LC, Buccafusco JJ. Adaptive changes in M1 muscarinic receptors localized to specific rostral brain regions during and after morphine withdrawal. Neuropharmacology. 39: 1720-31. PMID 10884554 DOI: 10.1016/S0028-3908(00)00012-5  0.335
2000 Buccafusco JJ, Zhang LC, Shuster LC, Jonnala RR, Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Research. 852: 76-83. PMID 10661498 DOI: 10.1016/S0006-8993(99)02197-6  0.79
1999 Buccafusco JJ, Jackson WJ, Jonnala RR, Terry AV. Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys. Behavioural Pharmacology. 10: 681-90. PMID 10780510 DOI: 10.1097/00008877-199911000-00015  0.809
1999 Zhang LC, Buccafusco JJ. Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms. Brain Research. 803: 114-21. PMID 9729319 DOI: 10.1016/S0006-8993(98)00635-0  0.373
1999 Terry A, Buccafusco J, Prendergast M. Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicotinic-cholinergic antagonist mecamylamine Drug Development Research. 47: 127-136. DOI: 10.1002/(Sici)1098-2299(199907)47:3<127::Aid-Ddr3>3.0.Co;2-#  0.689
1999 Terry A, Gattu M, Buccafusco J, Sowell J, Kosh J. Ranitidine analog, JWS-USC-75IX, enhances memory-related task performance in rats Drug Development Research. 47: 97-106. DOI: 10.1002/(Sici)1098-2299(199906)47:2<97::Aid-Ddr5>3.0.Co;2-I  0.679
1998 Canney DJ, Zhang M, Doukas PH, Massakowski C, Aronstam R, Gattu M, Buccafusco J. Characterization of ethyl (3-quinuclidinyl) acetate (EQA) as a ligand for acetylcholine receptors. Life Sciences. 63: PL329-36. PMID 9851313 DOI: 10.1016/S0024-3205(98)00502-5  0.445
1998 Paule MG, Bushnell PJ, Maurissen JP, Wenger GR, Buccafusco JJ, Chelonis JJ, Elliott R. Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicology and Teratology. 20: 493-502. PMID 9761587 DOI: 10.1016/S0892-0362(98)00013-0  0.322
1998 Prendergast MA, Buccafusco JJ. (-)-Nicotine increases mRNA encoding G3PDH and the vesicular acetylcholine transporter in vivo Neuroreport. 9: 1385-1389. PMID 9631434 DOI: 10.1097/00001756-199805110-00025  0.376
1998 Prendergast MA, Jackson WJ, Terry AV, Kille NJ, Arneric SP, Decker MW, Buccafusco JJ. Age-related differences in distractibility and response to methylphenidate in monkeys. Cerebral Cortex (New York, N.Y. : 1991). 8: 164-72. PMID 9542895 DOI: 10.1093/Cercor/8.2.164  0.6
1998 Terry AV, Buccafusco JJ, Jackson WJ, Prendergast MA, Fontana DJ, Wong EH, Bonhaus DW, Weller P, Eglen RM. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017. Psychopharmacology. 135: 407-15. PMID 9539266 DOI: 10.1007/S002130050529  0.627
1998 Prendergast MA, Jackson WJ, Terry AV, Decker MW, Arneric SP, Buccafusco JJ. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys. Psychopharmacology. 136: 50-8. PMID 9537682 DOI: 10.1007/S002130050538  0.669
1998 Prendergast MA, Terry AV, Buccafusco JJ. Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats. Neurotoxicology and Teratology. 20: 115-22. PMID 9536457 DOI: 10.1016/S0892-0362(97)00098-6  0.631
1997 Gattu M, Pauly JR, Urbanawiz S, Buccafusco JJ. Autoradiographic comparison of muscarinic M1 and M2 binding sites in the CNS of spontaneously hypertensive and normotensive rats. Brain Research. 771: 173-83. PMID 9401737 DOI: 10.1016/S0006-8993(97)00691-4  0.316
1997 Gattu M, Terry AV, Pauly JR, Buccafusco JJ. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II. Brain Research. 771: 104-14. PMID 9383013 DOI: 10.1016/S0006-8993(97)00794-4  0.671
1997 Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I. Brain Research. 771: 89-103. PMID 9383012 DOI: 10.1016/S0006-8993(97)00793-2  0.388
1997 Gattu M, Boss KL, Terry AV, Buccafusco JJ. Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus. Pharmacology, Biochemistry, and Behavior. 57: 793-9. PMID 9259008 DOI: 10.1016/S0091-3057(96)00391-7  0.614
1997 Buccafusco JJ, Shuster LC. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms. Brain Research Bulletin. 43: 321-6. PMID 9227843 DOI: 10.1016/S0361-9230(97)00013-0  0.379
1997 Gattu M, Wei J, Pauly JR, Urbanawiz S, Buccafusco JJ. Increased expression of M2 muscarinic receptor mRNA and binding sites in the rostral ventrolateral medulla of spontaneously hypertensive rats. Brain Research. 756: 125-32. PMID 9187322 DOI: 10.1016/S0006-8993(97)00126-1  0.368
1997 Prendergast MA, Buccafusco JJ, Terry AV. Nitric oxide synthase inhibition impairs spatial navigation learning and induces conditioned taste aversion. Pharmacology, Biochemistry, and Behavior. 57: 347-52. PMID 9164593 DOI: 10.1016/S0091-3057(96)00313-9  0.593
1997 Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliott RL, Gopalakrishnan M, Holladay MW, Hui YH, Jackson WJ, Kim DJ, Marsh KC, et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacology, Biochemistry, and Behavior. 57: 231-41. PMID 9164577 DOI: 10.1016/S0091-3057(96)00354-1  0.441
1997 Prendergast MA, Terry AV, Jackson WJ, Marsh KC, Decker MW, Arneric SP, Buccafusco JJ. Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacology. 130: 276-84. PMID 9151363 DOI: 10.1007/S002130050240  0.613
1997 Terry AV, Buccafusco JJ, Prendergast MA, Jackson WJ, Fontana DL, Wong EH, Whiting RL, Eglen RM. The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. Neuroreport. 8: 49-54. PMID 9051751 DOI: 10.1097/00001756-199612200-00011  0.611
1997 Prendergast MA, Terry AV, Buccafusco JJ. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology. 129: 183-91. PMID 9040125 DOI: 10.1007/S002130050179  0.61
1997 Lin NH, Gunn DE, Ryther KB, Garvey DS, Donnelly-Roberts DL, Decker MW, Brioni JD, Buckley MJ, Rodrigues AD, Marsh KG, Anderson DJ, Buccafusco JJ, Prendergast MA, Sullivan JP, Williams M, et al. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties. Journal of Medicinal Chemistry. 40: 385-90. PMID 9022806 DOI: 10.1021/jm960233u  0.319
1997 Prendergast MA, Terry AV, Jackson WJ, Buccafusco JJ. Nitric oxide synthase inhibition impairs delayed recall in mature monkeys. Pharmacology, Biochemistry, and Behavior. 56: 81-7. PMID 8981613 DOI: 10.1016/S0091-3057(96)00160-8  0.592
1997 Terry AV, Buccafusco J, Decker M. Cholinergic channel activator, ABT-418, enhances delayed-response accuracy in rats Drug Development Research. 40: 304-312. DOI: 10.1002/(Sici)1098-2299(199704)40:4<304::Aid-Ddr4>3.0.Co;2-N  0.66
1996 Feldman DS, Terry AV, Buccafusco JJ. Spinal muscarinic cholinergic and nitric oxide systems in cardiovascular regulation European Journal of Pharmacology. 313: 211-220. PMID 8911917 DOI: 10.1016/0014-2999(96)00513-4  0.588
1996 Terry AV, Buccafusco JJ, Jackson WJ, Zagrodnik S, Evans-Martin FF, Decker MW. Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task. Psychopharmacology. 123: 172-81. PMID 8741940 DOI: 10.1007/Bf02246174  0.686
1996 Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology. 120: 256-66. PMID 8524972 DOI: 10.1007/Bf02311172  0.687
1996 Buccafusco J, Prendergast M, Terry A, Jackson W. Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates Drug Development Research. 38: 196-203. DOI: 10.1002/(Sici)1098-2299(199607/08)38:3/4<196::Aid-Ddr8>3.0.Co;2-H  0.702
1995 Gattu M, Terry AV, Buccafusco JJ. A rapid microtechnique for the estimation of muscarinic and nicotinic receptor binding parameters using 96-well filtration plates. Journal of Neuroscience Methods. 63: 121-25. PMID 8788056 DOI: 10.1016/0165-0270(95)00100-X  0.612
1995 Wei J, Milici A, Buccafusco JJ. Alterations in the expression of the genes encoding specific muscarinic receptor subtypes in the hypothalamus of spontaneously hypertensive rats. Circulation Research. 76: 142-7. PMID 8001272 DOI: 10.1161/01.Res.76.1.142  0.385
1995 Buccafusco JJ, Jackson WJ, Gattu M, Terry AV. Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors. Neuroreport. 6: 1223-7. PMID 7662913 DOI: 10.1097/00001756-199505300-00037  0.686
1995 Buccafusco JJ, Terry AV, Shuster L. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Research. 679: 189-99. PMID 7633880 DOI: 10.1016/0006-8993(95)00203-3  0.589
1995 Jackson WJ, Buccafusco JJ, Terry AV, Turk DJ, Rush DK. Velnacrine maleate improves delayed matching performance by aged monkeys. Psychopharmacology. 119: 391-8. PMID 7480518 DOI: 10.1007/Bf02245854  0.604
1994 Holland LN, Shuster LC, Buccafusco JJ. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat. Neuropharmacology. 32: 1387-95. PMID 8152529 DOI: 10.1016/0028-3908(93)90035-2  0.378
1994 Xiaohong Yang, Buccafusco JJ, Pauly JR. Pharmacological evaluation of methylcarbamylcholine-induced drinking behavior in rats Pharmacology, Biochemistry and Behavior. 49: 1-6. PMID 7816857 DOI: 10.1016/0091-3057(94)90448-0  0.487
1994 Wei J, Walton EA, Milici A, Buccafusco JJ. m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. Journal of Neurochemistry. 63: 815-21. PMID 7519660 DOI: 10.1046/J.1471-4159.1994.63030815.X  0.313
1994 Yang X, Buccafusco JJ. Comparison of the ability of direct- and indirect-acting nicotinic agonists to induce nicotinic receptor up-regulation in rat cerebral cortex Drug Development Research. 31: 95-101. DOI: 10.1002/Ddr.430310203  0.488
1993 Terry AV, Buccafusco JJ, Jackson WJ. Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacology, Biochemistry, and Behavior. 45: 925-9. PMID 8415832 DOI: 10.1016/0091-3057(93)90141-F  0.676
1993 Terry AV, Jackson WJ, Buccafusco JJ. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys. Cerebral Cortex (New York, N.Y. : 1991). 3: 304-12. PMID 8400808 DOI: 10.1093/Cercor/3.4.304  0.63
1993 Buccafusco JJ, Yang X. Mechanism of the hypertensive response to central injection of nicotine in conscious rats. Brain Research Bulletin. 32: 35-41. PMID 8319101 DOI: 10.1016/0361-9230(93)90316-4  0.455
1993 Yang XH, Li W, Erwin L, Buccafusco JJ. Regulation of central muscarinic receptors after cholinesterase inhibition: effect of clonidine. Brain Research Bulletin. 32: 681-4. PMID 8221166 DOI: 10.1016/0361-9230(93)90173-9  0.41
1993 Feldman DS, Buccafusco JJ. Localization of cholinergic neurons involved in the cardiovascular response to intrathecal injection of carbachol European Journal of Pharmacology. 250: 483-487. PMID 8112410 DOI: 10.1016/0014-2999(93)90039-K  0.349
1992 Takahashi H, Buccafusco JJ. Excitatory modulation by a spinal cholinergic system of a descending sympathoexcitatory pathway in rats. Neuropharmacology. 31: 259-69. PMID 1630594 DOI: 10.1016/0028-3908(92)90176-P  0.305
1992 Buccafusco JJ, Jackson WJ, Terry AV. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by primates. Life Sciences. 51: PL 7-12. PMID 1614276 DOI: 10.1016/0024-3205(92)90011-D  0.651
1992 Buccafusco JJ. Neuropharmacologic and behavioral actions of clonidine: interactions with central neurotransmitters. International Review of Neurobiology. 33: 55-107. PMID 1350577 DOI: 10.1016/S0074-7742(08)60691-1  0.362
1991 Buccafusco JJ, Makari NF, Hays AC. Pharmacological analysis of the enhanced pressor response to central cholinergic stimulation in spontaneously hypertensive rats. Japanese Journal of Pharmacology. 54: 105-12. PMID 2077179 DOI: 10.1254/Jjp.54.105  0.371
1991 Buccafusco JJ. Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP). Life Sciences. 48: 749-56. PMID 1994183 DOI: 10.1016/0024-3205(91)90089-T  0.377
1991 Takahashi H, Buccafusco JJ. The sympathoexcitatory response following selective activation of a spinal cholinergic system in anesthetized rats. Journal of the Autonomic Nervous System. 34: 59-67. PMID 1940017 DOI: 10.1016/0165-1838(91)90008-Q  0.301
1991 Buccafusco JJ, Wei J, Kraft KL. The effect of the acetylcholine transport blocker vesamicol on central cholinergic pressor neurons. Synapse (New York, N.Y.). 8: 301-6. PMID 1925971 DOI: 10.1002/Syn.890080408  0.39
1991 Jackson WJ, Buccafusco JJ. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacology, Biochemistry, and Behavior. 39: 79-84. PMID 1924516 DOI: 10.1016/0091-3057(91)90400-V  0.376
1991 Buccafusco JJ, Jackson WJ. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiology of Aging. 12: 233-8. PMID 1876228 DOI: 10.1016/0197-4580(91)90102-P  0.478
1990 Buccafusco JJ, Magri V. Modification of spino-bulbar autonomic cholinergic systems by activation of alpha-adrenergic receptors. Journal of the Autonomic Nervous System. 28: 133-40. PMID 2576271 DOI: 10.1016/0165-1838(89)90086-6  0.376
1990 Buccafusco JJ, Heithold DL, Chon SH. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine. Toxicology Letters. 52: 319-29. PMID 2389260 DOI: 10.1016/0378-4274(90)90042-K  0.357
1990 Buccafusco JJ. Participation of different brain regions in the anti-narcotic withdrawal action of clonidine in the dependent rat. Brain Research. 513: 8-14. PMID 2350687 DOI: 10.1016/0006-8993(90)91083-S  0.344
1990 Buccafusco JJ, Magri V. The pressor response to spinal cholinergic stimulation in spontaneously hypertensive rats. Brain Research Bulletin. 25: 69-74. PMID 2207717 DOI: 10.1016/0361-9230(90)90254-W  0.353
1989 Magrí V, Buccafusco JJ. Hypertension following intrathecal injection of cholinergic agonists in conscious rats: role of endogenous acetylcholine. Journal of the Autonomic Nervous System. 25: 69-77. PMID 3225383 DOI: 10.1016/0165-1838(88)90009-4  0.359
1989 Makari NF, Trimarchi GR, Buccafusco JJ. Contribution of pre- and post-synaptic components to heightened central cholinergic activity in spontaneously hypertensive rats. Neuropharmacology. 28: 379-86. PMID 2747851 DOI: 10.1016/0028-3908(89)90033-6  0.37
1989 Buccafusco JJ, Graham JH, VanLingen J, Aronstam RS. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicology and Teratology. 11: 39-44. PMID 2725439 DOI: 10.1016/0892-0362(89)90083-4  0.382
1989 Smith MD, Yang XH, Nha JY, Buccafusco JJ. Antinociceptive effect of spinal cholinergic stimulation: interaction with substance P. Life Sciences. 45: 1255-61. PMID 2478855 DOI: 10.1016/0024-3205(89)90127-6  0.335
1988 Buccafusco JJ, Graham JH, Aronstam RS. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacology, Biochemistry, and Behavior. 29: 309-13. PMID 3362926 DOI: 10.1016/0091-3057(88)90161-X  0.351
1988 Elrod K, Buccafusco JJ. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmacology, Biochemistry, and Behavior. 29: 15-21. PMID 3353420 DOI: 10.1016/0091-3057(88)90267-5  0.366
1988 Magrí V, Buccafusco JJ, Aronstam RS. Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine. Toxicology and Applied Pharmacology. 95: 464-73. PMID 3188010 DOI: 10.1016/0041-008X(88)90364-X  0.391
1988 Buccafusco JJ, Aronstam RS, Graham JH. Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicology Letters. 42: 291-9. PMID 3176058 DOI: 10.1016/0378-4274(88)90114-2  0.332
1988 Elrod K, Buccafusco JJ, Jackson WJ. Nicotine enhances delayed matching-to-sample performance by primates. Life Sciences. 43: 277-87. PMID 2899825 DOI: 10.1016/0024-3205(88)90318-9  0.524
1988 Buccafusco JJ, Aronstam RS. Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology. 27: 227-33. PMID 2836749 DOI: 10.1016/0028-3908(88)90038-X  0.433
1988 Aronstam RS, Marshall DC, Buccafusco JJ. Cholinergic false transmitters: physiological and biochemical actions in central and peripheral systems. Neuropharmacology. 27: 217-25. PMID 2836748 DOI: 10.1016/0028-3908(88)90037-8  0.445
1987 Molloy AG, Aronstam RS, Buccafusco JJ. Selective antagonism by clonidine of the stereotyped and non-stereotyped motor activity elicited by atropine. Pharmacology, Biochemistry, and Behavior. 25: 985-8. PMID 3786370 DOI: 10.1016/0091-3057(86)90074-2  0.304
1987 Aronstam RS, Smith MD, Buccafusco JJ. Clonidine protection from soman and echothiophate toxicity in mice. Life Sciences. 39: 2097-102. PMID 3784771 DOI: 10.1016/0024-3205(86)90361-9  0.317
1987 Aronstam RS, Smith MD, Buccafusco JJ. Clonidine prevents the short-term down regulation of muscarinic receptors in mouse brain induced by the acetylcholinesterase inhibitor soman. Neuroscience Letters. 78: 107-12. PMID 3614769 DOI: 10.1016/0304-3940(87)90570-2  0.396
1987 Trimarchi GR, Buccafusco JJ. Changes in regional brain synaptosomal high affinity choline uptake during the development of hypertension in spontaneously hypertensive rats. Neurochemical Research. 12: 247-54. PMID 3495743 DOI: 10.1007/Bf00972134  0.322
1987 Buccafusco JJ, Aronstam RS. Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor. Toxicology Letters. 38: 67-76. PMID 2820088 DOI: 10.1016/0378-4274(87)90112-3  0.376
1986 Trimarchi GR, Glisson WC, Thomson WM, VanLingen J, Buccafusco JJ. Cholinergic neurons and the cardiovascular response produced by central injection of substance P in the normotensive rat. Life Sciences. 39: 1579-88. PMID 2429134 DOI: 10.1016/0024-3205(86)90390-5  0.416
1985 Buccafusco JJ. Inhibition of brain acetylcholine biosynthesis by methyldopa in spontaneously hypertensive rats. Brain Research Bulletin. 13: 257-62. PMID 6498532 DOI: 10.1016/0361-9230(84)90126-6  0.358
1985 Marshall DC, Buccafusco JJ. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats. Brain Research. 329: 131-42. PMID 4038893 DOI: 10.1016/0006-8993(85)90518-9  0.312
1985 Buccafusco JJ, Serra M. Role of cholinergic neurons in the cardiovascular responses evoked by central injection of bradykinin or angiotensin II in conscious rats European Journal of Pharmacology. 113: 43-51. PMID 2864263 DOI: 10.1016/0014-2999(85)90341-3  0.331
1985 Marshall DC, Buccafusco JJ. A comparison of the cardiovascular and the behavioral changes following naloxone as measures of the degree of physical dependence on morphine in rats Drug Development Research. 5: 271-280. DOI: 10.1002/Ddr.430050310  0.32
1984 Buccafusco JJ, Marshall DC, Turner RM. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats Life Sciences. 35: 1401-1408. PMID 6148677 DOI: 10.1016/0024-3205(84)90398-9  0.365
1984 Buccafusco JJ. Inhibition of regional brain acetylcholine biosynthesis by clonidine in spontaneously hypertensive rats Drug Development Research. 4: 627-633. DOI: 10.1002/Ddr.430040605  0.384
1983 Buccafusco JJ. Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine. Pharmacology, Biochemistry, and Behavior. 18: 209-15. PMID 6682228 DOI: 10.1016/0091-3057(83)90365-9  0.333
1982 Buccafusco JJ. Kinetics of [3H]choline and [3H]acetylcholine metabolism in several regions of rat brain following intracerebroventricular injection of [3H]choline. Effects of haloperidol. Biochemical Pharmacology. 31: 1599-605. PMID 7092951 DOI: 10.1016/0006-2952(82)90387-2  0.312
1982 Brezenoff HE, Carney K, Buccafusco JJ. Potentiation of the carotid artery occlusion reflex by a cholinergic system in the posterior hypothalamic nucleus. Life Sciences. 30: 391-400. PMID 7070215 DOI: 10.1016/0024-3205(82)90576-8  0.309
1982 Aronstam RS, Buccafusco JJ. Cholinergic actions of false neurotransmitters: acetyldiethylcholine. Neuroscience Letters. 28: 51-6. PMID 6278372 DOI: 10.1016/0304-3940(82)90207-5  0.409
1981 Buccafusco JJ, Aronstam RS. Cholinergic actions of false neurotransmitters: acetylpyrrolidinecholine. Neuroscience Letters. 23: 319-24. PMID 7266932 DOI: 10.1016/0304-3940(81)90018-5  0.424
1980 Buccafusco JJ, Brezenoff HE. Opposing influences on behavior mediated by muscarinic and nicotinic receptors in the rat posterior hypothalamic nucleus. Psychopharmacology. 67: 249-54. PMID 6770404 DOI: 10.1007/BF00431265  0.332
Show low-probability matches.